ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near ...

For years, Michelle Strickland had trouble sleeping – she woke up several times at night - and it left her with daytime ...

Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...

RADNOR, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension ...

My wife, who bore the brunt of my transformation into a grumpy badger, was the first to suggest I get a sleep study. She’d ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 ...

Most anti-snoring products won't be a permanent treatment for moderate to severe sleep apnea, but CPAP machines are still the gold standard for treatment. But if you're a mild snorer with no ...

The global durable medical equipment market size was valued at USD 232.33 billion in 2024 and is projected to grow from USD 243.31 billion in 2025 to reach USD 331.14 billion by 2033, exhibiting a ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.